An Overview. OCM's Enforcement Division. On March 31, 2021, the Marihuana Regulation & Taxation Act (MRTA) was signed into law, legalizing cannabis in New York State. This landmark legislation marked a significant shift in the state's approach to cannabis, allowing for its legal production, sale, and consumption for both medical and recreational purposes. The Office of Cannabis Management (OCM) was established to regulate this new industry and ensure compliance with the law.
Leaders in the state Office of Cannabis Management on Wednesday celebrated the opening of the state's 100th legal dispensary — putting on a display of the industry's growth and success. This milestone marked a significant achievement for the OCM and highlighted the increasing availability of legal cannabis products to consumers across the state.
The state is living up to the goals of the cannabis law to issue 50% of licenses to social equity licensees; a goal designed to deliver on promises of diversity and inclusion within the industry. This initiative aims to address the historical disparities in the cannabis market and provide opportunities for marginalized communities to participate in the legal cannabis industry.
Cannabis is legal in New York. Get the latest business news on cannabis production, retailing, municipal opt-outs, and business Regulation. Stay informed on the latest developments in the fast-growing cannabis industry in New York State.
New York State's much-maligned Office of Cannabis Management will get new leadership and streamline its torpid permitting process for businesses. The OCM has faced criticism for bureaucratic delays and inefficiencies in the licensing process, prompting calls for reform and improved efficiency in regulating the cannabis industry.
ALBANY, N.Y., March 18, 2024 – PRESS RELEASE – New York Gov. Kathy Hochul initiated an assessment of the state's Office of Cannabis Management to evaluate its performance and identify areas for improvement. This proactive approach demonstrates the state's commitment to ensuring effective oversight and Regulation of the cannabis industry.
The chemical used to justify a shutdown of a NY processor was approved for lab testing months ago, but the state didn't tell industry stakeholders. This lack of transparency has raised concerns among industry players about the regulatory process and the potential impact on businesses operating in the cannabis sector.
Chris Alexander wrote that he can no longer effective lead the Office of Cannabis Management “under current circumstances.” This statement reflects the challenges and pressures facing officials in overseeing the complex and rapidly evolving cannabis industry in New York State.
